Tyler Crowe

But one of the things that you were mentioning, we do have a pretty robust like disclosure and like no trade policy.

You know, if we know that a stock is going to be recommended like weeks in advance, we're not allowed to trade it.

If we talk about or write about any of the stocks that you hear us talking about on this podcast, we can't trade them for like multiple days.

And that's part of like

the process.

And I think at least for me, and I'm sure that you two agree on this to a certain degree, like it's one of the reasons I've enjoyed working for the Motley Fool for a long time is because, yeah, we get some things right.

We get some things wrong.

We can't say that we're perfect, but the, I think there's a level of transparency and disclosure with it when it comes to things like this, that separates us to a certain degree from the Citron research, you know, publishing something and then immediately trading on it afterwards.

So I, it,

You know, if it should be said, go ahead.

Yeah.

Well, you know, there's only so many Wall Street ethics episodes we can do here on a podcast.

But every once in a while, we're going to, you know, do our standing on our soapboxes.

And this is probably one of them.

Coming up after the break, we'll do listener questions.

Hey everyone, quick reminder, if you want to get your questions in, we love answering them.

Just send them over to podcasts at fool.com.

That's podcasts at fool.com.

The three quests we always ask is number one, keep it foolish.

Two, keep it short enough I can read on air.